Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

442 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Recombinant VSV-HIV Prime, DNA-Boost Vaccine Candidates on Immunogenicity and Viremia on SHIV-Infected Rhesus Macaques.
Berger A, Pedersen J, Kowatsch MM, Scholte F, Lafrance MA, Azizi H, Li Y, Gomez A, Wade M, Fausther-Bovendo H, de La Vega MA, Jelinski J, Babuadze G, Nepveu-Traversy ME, Lamarre C, Racine T, Kang CY, Gaillet B, Garnier A, Gilbert R, Kamen A, Yao XJ, Fowke KR, Arts E, Kobinger G. Berger A, et al. Among authors: kang cy. Vaccines (Basel). 2024 Mar 29;12(4):369. doi: 10.3390/vaccines12040369. Vaccines (Basel). 2024. PMID: 38675751
Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
Choi CH, Lee JW, Bae DS, Kang ES, Cho D, Kim YM, Kim K, Kim JW, Kim HS, Kim YT, Lee JY, Lim MC, Oh T, Song B, Jeon I, Park M, Kim WH, Kang CY, Kim BG. Choi CH, et al. Among authors: kang cy. Front Immunol. 2024 Mar 28;15:1371353. doi: 10.3389/fimmu.2024.1371353. eCollection 2024. Front Immunol. 2024. PMID: 38605958 Free PMC article. Clinical Trial.
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials.
Koh CH, Kim BS, Kang CY, Chung Y, Seo H. Koh CH, et al. Among authors: kang cy. Immune Netw. 2024 Jan 19;24(1):e2. doi: 10.4110/in.2024.24.e2. eCollection 2024 Feb. Immune Netw. 2024. PMID: 38455465 Free PMC article. Review.
Strategy to develop broadly effective multivalent COVID-19 vaccines against emerging variants based on Ad5/35 platform.
Chang S, Shin KS, Park B, Park S, Shin J, Park H, Jung IK, Kim JH, Bae SE, Kim JO, Baek SH, Kim G, Hong JJ, Seo H, Volz E, Kang CY. Chang S, et al. Among authors: kang cy. Proc Natl Acad Sci U S A. 2024 Mar 5;121(10):e2313681121. doi: 10.1073/pnas.2313681121. Epub 2024 Feb 26. Proc Natl Acad Sci U S A. 2024. PMID: 38408238 Free PMC article.
Boosting with variant-matched adenovirus-based vaccines promotes neutralizing antibody responses against SARS-CoV-2 Omicron sublineages in mice.
Shin KS, Kim BS, Chang S, Jung IK, Park H, Park S, Shin J, Kim JH, Han SJ, Park B, Kim JO, Lee JA, Lee TY, Kang CY. Shin KS, et al. Among authors: kang cy. Int J Antimicrob Agents. 2024 Mar;63(3):107082. doi: 10.1016/j.ijantimicag.2023.107082. Epub 2023 Dec 30. Int J Antimicrob Agents. 2024. PMID: 38163552 Free article.
442 results